Patents (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | |
---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Amortization expense | $ 646,912 | $ 646,912 | |
Rio Grande Neurosciences Inc [Member] | |||
Acquisition of patents | $ 4,500,000 | ||
Patents expiration period | 2024 |
X | ||||||||||
- Definition Patents expiration period. No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|